Australia markets closed

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.8000-0.0700 (-1.81%)
At close: 04:00PM EDT
3.8800 +0.08 (+2.11%)
After hours: 05:42PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
63,533
63,533
96,300
55,846
31,434
Operating expenses
Research development
172,596
172,596
320,454
215,519
125,623
Selling general and administrative
81,448
81,448
84,232
57,321
33,896
Total operating expenses
254,044
254,044
404,686
272,840
159,519
Operating income or loss
-190,511
-190,511
-308,386
-216,994
-128,085
Interest expense
-
-
-
0
0
Total other income/expenses net
12,397
12,397
20,823
3,534
-47,702
Income before tax
-160,928
-160,928
-281,721
-212,151
-173,387
Income from continuing operations
-160,928
-160,928
-281,721
-212,151
-173,387
Net income
-160,928
-160,928
-281,721
-212,151
-173,387
Net income available to common shareholders
-160,928
-160,928
-281,721
-212,151
-173,387
Basic EPS
-1.77
-1.64
-2.91
-2.24
-2.10
Diluted EPS
-1.77
-1.64
-2.91
-2.24
-2.10
Basic average shares
98,064
98,411
96,826
94,747
82,385
Diluted average shares
98,064
98,411
96,826
94,747
82,385